HIV News and Research

RSS

Substantial efforts needed to help people with HIV achieve durable viral suppression, study suggests

Among people with HIV worldwide who are receiving antiretroviral therapy (ART), adults are getting closer to the global target of 95% achieving viral suppression, but progress among children and adolescents is lagging and long-term viral suppression among all groups remains a challenge.

30 Nov 2021

Research finds low global HIV viral suppression rates among children and adolescents

Globally, less than two thirds of children living with HIV who are taking treatment are 'virally suppressed', according to new research from UNSW Sydney's Kirby Institute and the global IeDEA consortium, published today in The Lancet HIV.

30 Nov 2021

Telehealth-delivered exercise and weight loss program for people with knee osteoarthritis or obesity

A randomized trial found that video-based, telehealth-delivered exercise and weight loss programs with online educational support improved pain and function in people with knee osteoarthritis and overweight or obesity.

30 Nov 2021

Study suggests substantial efforts are needed to help people with HIV durably suppress the virus

30 Nov 2021

COVID-19 infections in the fully vaccinated are rare but are common in people with weak immune systems

A real-world retrospective cohort study involving nearly 1.2 million people shows COVID-19 infections in the 'fully' vaccinated are rare but are more common and severe in people with weaker immune systems.

30 Nov 2021

Improving access to health care is key to reducing HIV incidence

Many patients living with HIV in rural Africa are not receiving regular treatment, despite recent efforts to increase access to health care across the continent.

30 Nov 2021

Study on molnupiravir precursor NHC antiviral activity against SARS-CoV-2 variants of concern

In a new study, published on the bioRxiv* preprint server, scientists aimed to determine the reaction of the molnupiravir parent drug (NHC) to different SARS-CoV-2 Variants of Concern (VoCs). They also sought to establish the therapeutic window in a human lung cell model.

29 Nov 2021

Study finds atazanavir inhibits main SARS-CoV-2 protease

Research shows that ATV has different antiviral activity compared to PAXLOVID™, encouraging further research.

29 Nov 2021

Comprehensive genomic study maps the global resurgence of syphilis

The most comprehensive genomic study of syphilis to date has mapped the recent resurgence of the disease around the world.

26 Nov 2021

Discovering a new gene in monkeys that could help to develop new antivirals

We spoke to Dr. Nels Elde about his latest research that led to the discovery of a new gene in monkeys that could help to develop new antivirals.

26 Nov 2021

Research reveals how disordered protein interaction orchestrates gene expression

A team led by researchers at Baylor College of Medicine and the Czech Academy of Sciences has uncovered a new piece of the puzzle of how gene expression is orchestrated.

25 Nov 2021

Using metal nanoparticles to fight SARS-CoV-2

A recent review article looks at the potential of nanotechnology in fighting severe acute respiratory syndrome 2 (SARS-CoV-2), with several possibilities of strategies in therapeutics, vaccines, and prevention.

25 Nov 2021

UK's leading health charities team up to encourage vulnerable people to get COVID-19 vaccines

Some of the UK's leading health charities including the British Heart Foundation, Diabetes UK and Cancer Research UK are joining forces with the government and the NHS to encourage vulnerable people to get their COVID-19 vaccines.

25 Nov 2021

Researchers map how far HIV patients live from access to care

In sub-Saharan Africa, 7 million people with HIV live more than 10 minutes from health care services and 1.5 million people with HIV live more than 60 minutes from a healthcare facility, according to a new study published this week in the open-access journal PLOS Global Public Health by Diego Cuadros of the University of Cincinnati, and colleagues.

25 Nov 2021

HIV News and Research

Substantial efforts needed to help people with HIV achieve durable viral suppression, study suggests

Research finds low global HIV viral suppression rates among children and adolescents

Telehealth-delivered exercise and weight loss program for people with knee osteoarthritis or obesity

Study suggests substantial efforts are needed to help people with HIV durably suppress the virus

COVID-19 infections in the fully vaccinated are rare but are common in people with weak immune systems

Improving access to health care is key to reducing HIV incidence

Study on molnupiravir precursor NHC antiviral activity against SARS-CoV-2 variants of concern

Study finds atazanavir inhibits main SARS-CoV-2 protease

Comprehensive genomic study maps the global resurgence of syphilis

Discovering a new gene in monkeys that could help to develop new antivirals

Research reveals how disordered protein interaction orchestrates gene expression

Using metal nanoparticles to fight SARS-CoV-2

UK's leading health charities team up to encourage vulnerable people to get COVID-19 vaccines

Researchers map how far HIV patients live from access to care

Scientists now close to eliminating mother-baby HIV transmission, says leading researcher

Time of starting antiretroviral therapy can influence tumor development In HIV patients

WHO’s C-TAP and MPP finalize licensing agreement with CSIC for COVID-19 serological antibody technology

Western diet has high levels of blood lipids associated with systemic inflammation, study finds

Researchers make progress towards a new diagnostic test for schistosomiasis

Red blood cell distribution width as a biomarker for COVID-19

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News